Cormorant Asset Management’s BlossomHill Therapeutics BLSM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLSM
Cormorant Asset Management's BLSM Position: Q3 2026 in Review
Cormorant Asset Management opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 3,614,034 shares worth $67.4M. The stake represents 4.52% of the portfolio and ranks #7 among its holdings.
39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.
- Cormorant Asset Management held 3,614,034 shares of BlossomHill Therapeutics worth $67.4M as of Q3 2026.
- BlossomHill Therapeutics was a new Cormorant Asset Management position in Q3 2026.
- BlossomHill Therapeutics made up 4.52% of Cormorant Asset Management's portfolio in Q3 2026, its #7 holding.
- 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.
Based on Cormorant Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.